Abstract
The studies on the cancer immunology and its application to the cancer immunotherapy in humans are attractive subjects for the immunologists and oncologists. However, in order to discuss the immunostimulation and its application to cancer patients, the following should be considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Azuma, I., T. Taniyama, F. Hirao and Y. Yamamura. 1974. Antitumor activity of cell wall skeletons and peptidoglycolipids of mycobacteria and related microorganisms in mice and rabbits. Gann 65: 493.
Azuma, I., and Y. Yamamura. 1979. Immunotherapy of cancer with BCG cell-wall skeleton and related materials. Gann Monogr. Cancer Res. 24: 121.
Cheever, M. A., P. D. Greenberg and A. Fefer. 1981. Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and non-specifically expanded by culture with interleukin 2. J. Immunol. 126: 1318.
Cheever, M. A., P. D. Greenberg, A. Fefer and S. Gillis. 1982. Augmentation of the anti-tumor therapeutic efficacy of longterm cultured T lymphocytes by in vivo administration of purified interleukin. J. Exp. Med. 155: 968.
Ellouz, F., A. Adam, R. Ciorbaru and E. Lederer. 1974. Minimal structure requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59: 1317.
Gutterman, J. U., S. Fein, J. Quesada, S. J. Horning, J. L. Levine, R. Alexanian, L. Bernhardt, M. Kramer, H. Speigel, W. Colburn, P. Trown, T. Merigan and Z. Dziewanowska. 1982. Recombinant leukocyte A interferon: Pharmacokinetics, single dose tolerance and biologic effects in cancer patients. Annals of Int. Med. (in press).
Fidler, I. J., S. Sone, W. E. Fogler and J. L. Barnes. 1981. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc. Natl. Acad. Sci. USA 78: 1680.
Fidler, I. J., S. Sone, W. E. Fogler, D, Smith, D. G. Braun, L. Tarcsay, R. J. Gisler and A. J. Schroit. 1982. Efficacy of liposomes containing a lipophilic muramyl dipeptide derivative for activating the tumoricidal properties of alveolar macrophages in vivo. J. Biol. Response Modifiers (in press).
Hatzubai, A., D. G. Malone, R. Levy. 1981. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma. J. Icmuunol. 126: 2397.
Irie, R. F., P. C. Jones, D. L. Morton and N. Sidell. 1981. In vitro production of human antibody to a tumour-associated foetal antigen. Br. J. Cancer 44: 262.
Jones, P. C., L. L. Sze, P. Y. Liu, D. L. Morton and R. F. Irie. 1981. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J. Natl. Cancer Inst. 66: 249.
Kaieda, T., M. Okada, N. Yoshimura, S. Kishimoto, Y. Yamamura and I. Azuma. 1982. A human helper T cell clone secreting both killer helper factor(s) and T cell-replacing factor(s). J. Immunol. 129: 46.
Kotani, S., Y. Watanabe, F. Kinoshita, T. Shimono, I. Morisaki, T. Shiba, S. Kusumoto, Y. Tarumi and K. Ikenaka. 1975. Immunoadjuvant activities of synthetic N-acetylmuramylpeptides or amino acids. Biken J. 18: 105.
Lederer, E. 1982. Immunomodulation by muramyl peptides: Recent developments. Clin. Immunol. Newsletter 3: 83.
Lotze, M.T., E. A. Grimm, A. Mazumder, J. L. Strausser and S. A. Rosenberg. 1981. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res. 41: 4420.
Lotze, M. T., B. R. Line, D. J. Mathisen and S. A. Rosenberg. 1980. The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGFP: Implications for the adoptive immunotherapy of tumors. J. Immunol. 125: 1487.
Magnani, J. L., M. Brockhaus, D. F. Smith, V. Ginsburg, M. Blaszcayk, K. F. Mitchell, Z. Steplewski and H. Koprowski. 1981. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212: 55.
Marx, J. L. 1982. Monoclonal antibodies in cancer. Science 216: 283.
McKneally, M. F., C. Mayer, L. Lininger, H. W. Kausel, J. B. Mcllduff, T. M. Older, E. D. Foster and R. D. Alley. 1981. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer. J. Thorac. Cardiovas. Surg. 81: 485.
Miller, R. A. and R. Levy. 1981. Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet 2: 226.
Miller, R. A., D. G. Maloney, J. McKillop, and R. Levy. 1981. In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood 58: 78.
Miller, R. A., D. G. Maloney, R. Warnke, and R. Levy. 1982. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. New Eng. J. Med. 306: 517.
Moller, G. (ed.). 1982. Antibody Carriers of Drugs and Toxins in Tumor Therapy. Immunol. Rev., Vol. 62.
Mountain, C. F. and M. H. Gail. 1981. Surgical adjuvant intra-pleural BCG treatment for Stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 82: 649.
Ogura, T., M. Namba, Y. Yamamura and I. Azuma. 1979. Immunotherapeutic effect of BCG and Nocardia rubra cell-wall skeletons on syngeneic tumors in rats. In W. D. Terry and Y. Yamamura (eds.) Immunobiology and Immunotherapy of Cancer. Elsevier North/Holland Publishers, New York.
Okada, M., N. Yashimura, T. Kaieda, Y. Yamamura and T. Kishimoto. 1981. Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc. Natl. Acad. Sci. USA 78: 7717.
Pukel, C. S., K. O. Lloyd, L. R. Travasos, W. G. Dippold, H. F. Oettgen and L. J. Old. 1982. GD3 a prominent ganglioside of human melanoma. J. Exp. Med. 155: 1133.
Ritz, J., J. M. Pesando, J. Notis-McConarty, H. Lazarus and S. Schlossman. 1980. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature 283: 583.
Ritz, J., J. M. Pesando, S. E. Sallan, L. A. Clavell, J. Notis-McConarty, P. Rosenthal and S. F. Schlossman. 1981. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 58: 141.
Saiki, I., Y. Tanio, M. Yamawaki, M. Uemiya, S. Kobayashi, T. Fukuda, H. Yukimasa, Y. Yamamura and I. Azuma. 1981. Adjuvant activity of quinonyl-N-acetylmuramyldipeptides in mice and guinea pigs. Infect. Immun. 31: 114.
Sato, H., T. Ochiai, H. Sato, R. Hayashi, K. Watanabe, T. Asano, K. Isono and T. Tanaka. 1982. Result of randomized clinical trial of immunotherapy with Nocardia rubra-CWS. J. Jap. Surg. Soc. (in Japanese) (in press).
Terry, W. D. and S. T. Rosenberg (ed). 1982. Immunotherapy of Human Cancer. Excepta Medica, Amsterdam.
Umezawa, H., T. Aoyagi, H. Suda, M. Hamada and T. Takeuchi. 1976. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J. Antibiot. 29: 97.
Yamamura, Y., I. Azuma, K. Sugimura, M. Yamawaki, M. Uemiya, S. Kusumoto, S. Okada and T. Shiba. 1976. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine. Gann 67: 867.
Yamamura, Y., M. Sakatani, T. Ogura and I. Azuma. 1979. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS). Cancer 43: 1314.
Yamamura, Y., T. Ogura, M. Sakatani, F. Hirao, S. Kishimoto, K. Furuse, M. Kawahara, M. Fukuoka, M. Takada, O. Kuwahara and N. Ogawa. 1982a. Randomized controlled study on adjuvant immunotherapy for unresectable lung cancer with Nocardia rubra cell wall skeleton. Gan to Kagakuryoho (in Japanese) (in press).
Yamamura, Y., T. Ogura, M. Sakitani, F. Hirao, S. Kishimoto, K. Furuse, M. Kawahara, M. Fukuoka, M. Takada, O. Kuwahara, H. Ikegami, S. Nakamura and N. Ogawa. 1982b. Clinical effect of Nocardia rubra cell wall skeleton (N-CWS) on lung cancer with malignant pleural effusion. Gan to Kagakuryoho (in Japanese) (in press).
Yamamura, Y., K. Yasumoto, T. Ogura and I. Azuma. 1981. Nocardia rubra cell wall skeleton in the therapy of animal and human cancer. In E. M. Hersh (ed.), Augmenting Agents in Cancer Immunology. Raven Press, New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yamamura, Y., Azuma, I. (1983). Immunostimulation in Cancer Patients. In: Klein, T., Specter, S., Friedman, H., Szentivanyi, A. (eds) Biological Response Modifiers in Human Oncology and Immunology. Advances in Experimental Medicine and Biology, vol 166. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1410-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1410-4_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1412-8
Online ISBN: 978-1-4757-1410-4
eBook Packages: Springer Book Archive